BeStock  
Stocks › Biotechnology › NUVB

Nuvation Bio NUVB

US equityMarket cap rank #2886Biotechnology
$4.95 −$0.19 (-3.70%)
Market closed · Oct 6, 1:30 am ET · Last extended-hours $4.96 +0.20%
Open$5.12
Prev close$5.14
Day range$4.85 – $5.16
Volume9.97M
Market cap$1.74B
P/E (TTM)–
Dividend yield–

Fundamentals

Latest reported quarter: ANNUAL, ended Dec 2025

Revenue$62.90M+699.0% YoY
Operating profit-$213.06M-27.2% YoY
Net profit-$204.63M+64.0% YoY
Diluted EPS-$0.60+71.6% YoY

Annual revenue

$0.0FY20$0.0FY21$0.0FY22$0.0FY23$7.9MFY24$62.9MFY25

Profitability & balance sheet

Gross margin85.2%
Operating margin-338.7%
Net margin-325.3%
Liabilities / assets65.9%
Cash & investments$660.96M
Total debt$250.43M
Net cash (debt)$410.53M

Balance sheet

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Total Assets $744.50M $610.24M $594.82M $594.82M $601.56M
Total Current Assets $726.43M $591.53M $571.52M $571.52M $577.53M
Cash and Cash Equivalents & Short-Term Investments $660.96M $533.73M $529.21M $529.21M $549.05M
-Cash and Cash Equivalents $258.60M $125.39M $164.09M $164.09M $98.90M
-Short Term Investments $402.35M $408.34M $365.13M $365.13M $450.15M
Receivables $31.71M $25.98M $19.36M $19.36M $13.85M
-Accounts Receivable $27.83M $22.72M $16.08M $16.08M $8.32M
-Accrued Interest Receivable $3.89M $3.26M $3.29M $3.29M $5.53M
Inventory $19.90M $15.84M $11.41M $11.41M $5.71M
Other Current Assets $13.86M $15.97M $11.54M $11.54M $8.93M
Total Non-Current Assets $18.07M $18.71M $23.30M $23.30M $24.03M
Net PPE $3.96M $4.13M $4.48M $4.48M $4.89M
-Gross PPE $5.29M $5.39M $5.67M $5.67M $6.00M
-Accumulated Depreciation -$1.33M -$1.26M -$1.18M -$1.18M -$1.11M
Goodwill and Other Intangible Assets $10.29M $10.76M $11.21M $11.21M $11.68M
Other Non-Current Assets $3.82M $3.82M $7.61M $7.61M $7.46M
Total Liabilities $490.64M $290.68M $289.11M $289.11M $275.68M
Total Current Liabilities $86.76M $79.52M $82.23M $82.23M $68.13M
Payables $12.09M $22.44M $9.77M $9.77M $15.36M
-Accounts Payable $12.09M $22.44M $9.48M $9.48M $15.36M
Current Accrued Expenses $45.20M $32.86M $24.90M $24.90M $32.58M
Short-Term Debt and Capital Lease Obligation $7.61M $7.63M $7.60M $7.60M $7.49M
-Current Debt $5.89M $5.79M $5.72M $5.72M $5.62M
-Current Capital Lease Obligation $1.72M $1.84M $1.88M $1.88M $1.87M
Current Deferred Liabilities $8.86M $8.65M $7.52M $7.52M $12.70M
Other Current Liabilities $13.00M $7.94M $12.45M $12.45M –
Total Non-Current Liabilities $403.88M $211.16M $206.88M $206.88M $207.55M
Long Term Debt and Capital Lease Obligation $244.53M $49.53M $49.75M $49.75M $50.06M
-Long Term Debt $242.62M $47.33M $47.21M $47.21M $47.09M
-Long Term Capital Lease Obligation $1.91M $2.20M $2.54M $2.54M $2.97M
Non-Current Deferred Liabilities $8.23M $9.74M $11.31M $11.31M $155.75M
Other Non-Current Liabilities $151.12M $151.89M $145.82M $145.82M –
Total Equity $253.86M $319.56M $305.72M $305.72M $325.88M
Stockholders' Equity $253.86M $319.56M $305.72M $305.72M $325.88M
Capital Stock $1.43B $1.43B $1.42B $1.42B $1.40B
-Common Stock $1.43B $1.43B $1.42B $1.42B $1.40B
Retained Earnings -$1.17B -$1.11B -$1.12B -$1.12B -$1.08B
Gains/Losses Not Affecting Retained Earnings -$2.61M -$1.68M -$187,000.00 -$187,000.00 -$139,000.00
-Total Tax Payable – – $286,000.00 $286,000.00 –
Derivative Product Liabilities – – $0.00 $0.00 $1.74M

Income statement

Line item 2025 ANNUAL 2024 ANNUAL 2023 ANNUAL 2022 ANNUAL 2021 ANNUAL
Total Revenue as Reported $62.90M $7.87M $0.00 – –
Total Operating Revenue $62.90M $7.87M $0.00 $0.00 $0.00
Cost of Revenue $9.30M $7.08M $0.00 – –
Gross Profit $53.60M $795,000.00 $0.00 – –
Operating Expense $266.67M $168.35M $99.82M $119.73M $93.32M
Selling and Admin Expenses $151.56M $69.23M $28.53M $31.92M $24.28M
Research & Development $115.11M $99.12M $71.29M $87.82M $69.04M
Operating Profit -$213.06M -$167.56M -$99.82M -$119.73M -$93.32M
Net Non-Operating Interest Income (Expense) $7.75M $26.72M $24.61M $7.45M $2.96M
Non-Operating Interest Income $21.43M $27.06M $24.61M $7.45M $2.96M
Non-Operating Interest Expense $13.68M $341,000.00 $0.00 – –
Other Income (Expense) $689,000.00 -$427.10M -$591,000.00 $8.09M $3.51M
Gain on Sale of Security -$807,000.00 -$948,000.00 $358,000.00 $8.96M $4.15M
Special Income (Charges) -$33,000.00 -$425.07M $0.00 – –
-Gain on Sale of Property/Plant/Equipment -$33,000.00 $0.00 – – –
Other Non-Operating Income (Expenses) $1.53M -$1.09M -$949,000.00 -$872,000.00 -$644,000.00
Pretax Profit -$204.63M -$567.94M -$75.80M -$104.20M -$86.85M
Tax $0.00 $0.00 $0.00 $0.00 $0.00
Net Profit -$204.63M -$567.94M -$75.80M -$104.20M -$86.85M
Profit from Continuing Operations -$204.63M -$567.94M -$75.80M -$104.20M -$86.85M
Net Income to Parent Company -$204.63M -$567.94M -$75.80M -$104.20M -$86.85M
Net Income to Common Stockholders -$204.63M -$567.94M -$75.80M -$104.20M -$86.85M
Basic EPS -$0.60 -$2.11 -$0.35 -$0.48 -$0.44
Diluted EPS -$0.60 -$2.11 -$0.35 -$0.48 -$0.44
-Less:Other Special Charges – $425.07M – – –
-General & Admin Expense – – – $31.92M $24.28M

Discussion

No comments yet — be the first to weigh in on NUVB.

Leave a comment

Scroll to Top